Stage Iii Uterine Corpus Cancer Ajcc V6: Disease Bioinformatics
Uterine Cancer, also referred to as uterine corpus cancer, is localized in the uterus and is frequently referred to as endometrial cancer because it forms in the lining of the uterus (the endometrium). Uterine cancer is the fourth most common cancer in women and is the most frequently diagnosed gynecologic cancer. It usually occurs during/after menopause and risk in increased with obesity and taking estrogenalone hormone replacement therapy. Treatment is typically a hysterectomy, removal the uterus, ovaries, and fallopian tubes but hormone therapy and radiation are other treatment options if found appropriate. In stage III of uterine corpus cancer, the cancer's progression can be divided into three segments: IIIA, IIIB, and IIIC1/2. In stage III, the cancer is beginning to spread in the pelvic region such as the vagina, uterus, fallopian tubes, and ovaries, but has not localized in distant locations throughout the body.
Stage Iii Uterine Corpus Cancer Ajcc V6 Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Uterine Corpus Cancer Ajcc V6 below!
For more information on how to use Laverne, please read the How to Guide.
We have 1156 products for the study of Stage Iii Uterine Corpus Cancer Ajcc V6 that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.